box10.gif (1299 bytes)

 

 

 

 

 

 

Companies

Medical-business accelerator receives $1.19 million

WINNIPEG – Manitoba’s growing life sciences cluster may soon be able to get its ideas to market faster with a $1.19 million investment from Western Economic Diversification Canada (WD). Biomedical Commercialization Canada, a life sciences business accelerator, will use the funds to provide innovators and entrepreneurs with the business tools they need to become successful.

Steven Fletcher, Member of Parliament for Charleswood-St.James-Assiniboia, made the announcement on behalf of the Honourable Carol Skelton, Minister of National Revenue and Minister of Western Economic Diversification.

According to a 2004 KPMG study of medical devices production in 11 countries, Canada ranks first worldwide, with a 5.6% cost advantage over the United States. Building on this opportunity, Biomedical Commercialization Canada Inc. (BCC) was launched in 2005 in Winnipeg, in the Commercialization Centre for Biomedical Technologies.

This business incubator for biomedical technologies works with entrepreneurs and start-up companies to help commercialize research and technology and connect know-how into useful products.

Recognizing the need for global relationships, BCC has developed a working relationship with the Canterbury Enterprise Hub at the University of Kent to promote collaboration between Canadian and UK biomedical technology and markets.

“Manitoba’s life sciences cluster presents economic opportunities for the province and promises medical innovation for all Canadians,” said Fletcher. “Canada’s new government made a commitment to creating an environment that supports jobs and growth, and we are honouring that commitment to Canadians.

Innovators and entrepreneurs looking to move new technologies from the laboratory to the marketplace need specialized assets and infrastructure in areas such as business operations, management, data security and quality control. Biomedical Commercialization Canada (BCC) will provide these business applications in a secure and accessible environment that will also allow clients to collaborate with partner companies in Manitoba and around the world.

“By creating a shared business environment, we can reduce cost and provide clients with the programs they will need to be successful,” said Joe Wery, BCC President and CEO. “We will not only provide the business tools, but we will also show them how to use these tools to establish best business practices that will increase their investment opportunity.”

The life sciences sector in Manitoba consists of companies and research institutions that have expertise in cardiovascular and respiratory diseases, infections diseases, diagnostics, medical devices, and pharmaceuticals. Examples include the National Research Council Institute for Bio-diagnostics, the Canada Science Centre for Human and Animal Health, the St. Boniface General Hospital Research Centre and the University of Manitoba.

Biomedical Commercialization Canada Inc. is a not-for-profit organization founded by the National Research Council of Canada and the Province of Manitoba. Led by a private sector board of directors, BCC designs, implements and manages a suite of technology commercialization services and programs for Canadian biomedical technology and related firms.

Western Economic Diversification Canada (WD) is a department of the Government of Canada that works in partnership with the provinces, industry associations and communities to stimulate and encourage diversification of the western economy, as well as to represent the interests of the West in national decision-making.

For more information, please visit www.biomedcanada.com at www.biomedcanada.com, or email Marshall Ring, Senior Program Development Officer, BCC, at info@biomedcanada.com.

 

HOME - CURRENT ISSUE - ABOUT US - SUBSCRIBE - ADVERTISE - ARCHIVES - CONTACT US - EVENTS - LINKS